logo

SOLV

Solventum·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 5
High Gross Profit Margin
Significant Net Income Growth
Price Hits New Low
Price Hits 52-week Low
RSI Overbought
EPS Below Expectations
Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About SOLV

Solventum Corporation

A company focused on healthcare challenges, with businesses spanning medical solutions, oral care, and health information technology.

Healthcare Technology
--
04/01/2024
New York Stock Exchange
22,000
12-31
Common stock
3M Center, Building 275-6W 2510 Conway Avenue East, Maplewood, Minnesota 55144
--
Solventum Corporation was founded in Delaware. Solventum is a leading global healthcare company that develops, manufactures and commercializes a broad portfolio of solutions that leverage deep material science, data science and digital capabilities to meet critical customer and patient needs. They continuously seek to improve the standard of care and drive innovation through insight, clinical intelligence, technology and manufacturing expertise to drive healthcare forward.

Earnings Call

Company Financials

EPS

SOLV has released its 2025 Q3 earnings. EPS was reported at 1.5, versus the expected 1.43, beating expectations. The chart below visualizes how SOLV has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SOLV has released its 2025 Q3 earnings report, with revenue of 2.10B, reflecting a YoY change of 0.67%, and net profit of 1.27B, showing a YoY change of 937.70%. The Sankey diagram below clearly presents SOLV's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime